Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Adam Green, MD

Pediatric Hematology / Oncology

Board Certified

Adam Green

Care Philosophy

I am committed to providing exceptional child- and family-centered care to my patients. I strive to communicate information truthfully to families at all times, and in an age-appropriate way to patients throughout childhood. As part of a team that includes physicians, advanced practice practitioners, nurses, social workers, and others, I aim to provide the highest quality, most innovative care to all patients from Colorado and beyond, to maximize cure rates and minimize adverse effects of treatment.

Clinical Interest for Patients

I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma, and radiation-induced glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord.

Title(s)

Attending Physician

Credentials

Doctor of Medicine

Specialty

Pediatrics, Pediatric Hematology / Oncology

Scheduling Phone Number

720-777-1234

Gender

Male

Languages

Spanish, English

Hospital Affiliation

Children's Hospital Colorado

Provider Information

  • Pediatrics (2010)
  • Pediatric Hematology / Oncology (2015)
  • Cancers

    Pediatric Cancer , Brain Cancer

  • Brain and Nervous System

    Brain Tumors

  • Child and Teen Health

Personal Interests
Spending time with my wife and three children, playing piano, singing, road cycling, running, and tennis.


Volunteer Activities
I enjoy educating the community on childhood cancer research and advocating for our patients. I am also a volunteer youth baseball coach.


Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation

Children's Oncology Group, Member, CNS Committee Society for Neuro-Oncology, Member University of Colorado Cancer Center, Full Member

Grants

R01: Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas (2024)

Research Interests for Patients

My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse midline glioma, diffuse hemispheric glioma, and radiation-induced glioma. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials. We are also interested in combination therapy, resistance to therapy, and methods to bypass the blood-brain barrier. I also have a separate research effort investigating and addressing demographic, socioeconomic, and geographic disparities in pediatric cancer outcomes.

Education and Training

Medical Schools

MD, New York University School of Medicine (2006)


Undergraduate Schools

BA, Dartmouth College (NH) (2002)


Internships

University of Colorado (Children's Hospital Colorado) Program (2007)


Residency Program

University of Colorado (Children's Hospital Colorado) Program (2010)

University of Colorado (Children's Hospital Colorado) Program (2009)


Fellowships

Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School Program (2013)

Information for referring providers

Referral Contact Phone

720-777-1234

720-777-1234

Referring Patients Link

Information for Referring and Transferring Patients

Clinical Interests for Referring Providers

I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma, and radiation-induced glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord.

Research Interest for Referring Providers

My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse midline glioma, diffuse hemispheric glioma, and radiation-induced glioma. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials. We are also interested in combination therapy, resistance to therapy, and methods to bypass the blood-brain barrier. I also have a separate research effort investigating and addressing demographic, socioeconomic, and geographic disparities in pediatric cancer outcomes.